157 related articles for article (PubMed ID: 37116605)
1. Prognostic significance of serial N-terminal pro-B-type natriuretic peptide levels in patients with acute myocardial infarction: A prospective study.
Li N; Chen R; Li J; Zhao X; Wang Y; Zhou J; Zhou P; Liu C; Chen Y; Song L; Yan S; Zhao H; Yan H
Am Heart J; 2023 Aug; 262():90-99. PubMed ID: 37116605
[TBL] [Abstract][Full Text] [Related]
2. Optimization of GRACE Risk Stratification by N-Terminal Pro-B-type Natriuretic Peptide Combined With D-Dimer in Patients With Non-ST-Elevation Myocardial Infarction.
Lu PJ; Gong XW; Liu Y; Tian FS; Zhang WJ; Liu YW; Yao ZH; Wang JX; Han P; Yang YN; Cui Z; Gao J
Am J Cardiol; 2021 Feb; 140():13-19. PubMed ID: 33159905
[TBL] [Abstract][Full Text] [Related]
3. Association between N-terminal pro-BNP and 12 months major adverse cardiac events among patients admitted with NSTEMI.
Gong X; Zhang T; Feng S; Song D; Chen Y; Yao T; Han P; Liu Y; Li C; Song Z; Gao J; Cui Z; Ma J; Liu Y
Ann Palliat Med; 2021 May; 10(5):5231-5243. PubMed ID: 34044561
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of Preprocedural N-Terminal Pro-B-Type Natriuretic Peptide Assessment in Diabetic Patients With Multivessel Coronary Disease Undergoing Revascularization.
Wang L; Cong HL; Zhang JX; Hu YC; Li XM; Zhang YY; Wang L; Yang H; Ren LB; Qi W; Liu CW
Front Cardiovasc Med; 2021; 8():721260. PubMed ID: 34692781
[No Abstract] [Full Text] [Related]
5. Early discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk Score.
Schellings DA; Adiyaman A; Giannitsis E; Hamm C; Suryapranata H; Ten Berg JM; Hoorntje JC; Van't Hof AW
J Am Heart Assoc; 2014 Nov; 3(6):e001089. PubMed ID: 25389283
[TBL] [Abstract][Full Text] [Related]
6. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation.
Niccoli G; Conte M; Marchitti S; Montone RA; Fracassi F; Grippo R; Roberto M; Burzotta F; Trani C; Leone AM; Bianchi F; Di Castro S; Volpe M; Crea F; Rubattu S
Cardiovasc Revasc Med; 2016; 17(3):162-8. PubMed ID: 26987266
[TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy.
van Diepen S; Newby LK; Lopes RD; Stebbins A; Hasselblad V; James S; Roe MT; Ezekowitz JA; Moliterno DJ; Neumann FJ; Reist C; Mahaffey KW; Hochman JS; Hamm CW; Armstrong PW; Granger CB; Theroux P;
Int J Cardiol; 2013 Oct; 168(3):2127-33. PubMed ID: 23394896
[TBL] [Abstract][Full Text] [Related]
8. Proenkephalin and prognosis after acute myocardial infarction.
Ng LL; Sandhu JK; Narayan H; Quinn PA; Squire IB; Davies JE; Bergmann A; Maisel A; Jones DJ
J Am Coll Cardiol; 2014 Jan; 63(3):280-9. PubMed ID: 24140658
[TBL] [Abstract][Full Text] [Related]
9. The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study.
He WF; Jiang L; Chen YY; Liu YH; Chen PY; Duan CY; Zeng LH; Fan HL; Wei XB; Guo W; Chen W; Li J; Li WS; Guo ZQ; Liu ZK; Tan N; Chen JY; He PC
BMC Cardiovasc Disord; 2021 Apr; 21(1):202. PubMed ID: 33882836
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between plasma N-terminal pro-brain natriuretic peptide and GRACE risk stratification in non-ST-segment elevation acute coronary syndrome].
Liu WX; Zhao H
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):373-7. PubMed ID: 22883085
[TBL] [Abstract][Full Text] [Related]
11. The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.
Vernooij LM; van Klei WA; Moons KG; Takada T; van Waes J; Damen JA
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013139. PubMed ID: 34931303
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of NT-proBNP in Patients With Successful PCI for ACS and Normal Left Ventricular Ejection Fraction.
Wang JL; Guo CY; Li HW; Zhao XQ; Zhao SM
Am J Med Sci; 2022 Apr; 363(4):333-341. PubMed ID: 34986361
[TBL] [Abstract][Full Text] [Related]
13. Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome.
Widera C; Pencina MJ; Meisner A; Kempf T; Bethmann K; Marquardt I; Katus HA; Giannitsis E; Wollert KC
Eur Heart J; 2012 May; 33(9):1095-104. PubMed ID: 22199121
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial.
Jering KS; Claggett BL; Pfeffer MA; Granger CB; Køber L; Lewis EF; Maggioni AP; Mann DL; McMurray JJV; Prescott MF; Rouleau JL; Solomon SD; Steg PG; von Lewinski D; Braunwald E
Circ Heart Fail; 2023 May; 16(5):e010259. PubMed ID: 37125529
[TBL] [Abstract][Full Text] [Related]
15. Combined use of high-sensitivity ST2 and NT-proBNP for predicting major adverse cardiovascular events in coronary heart failure.
Bai J; Han L; Liu H
Ann Palliat Med; 2020 Jul; 9(4):1976-1989. PubMed ID: 32762223
[TBL] [Abstract][Full Text] [Related]
16. Relationship of Red Cell Volume Distribution Width and N-Terminal Pro-Brain Natriuretic Peptide with Severity and Prognosis of Patients with Acute Coronary Syndrome Receiving Percutaneous Coronary Intervention.
Pan R
Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255302
[TBL] [Abstract][Full Text] [Related]
17. B-type natriuretic peptides for the prediction of cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study.
Mishra RK; Beatty AL; Jaganath R; Regan M; Wu AH; Whooley MA
J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25053234
[TBL] [Abstract][Full Text] [Related]
18. N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.
Haaf P; Balmelli C; Reichlin T; Twerenbold R; Reiter M; Meissner J; Schaub N; Stelzig C; Freese M; Paniz P; Meune C; Drexler B; Freidank H; Winkler K; Hochholzer W; Mueller C
Am J Med; 2011 Aug; 124(8):731-9. PubMed ID: 21787902
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
[TBL] [Abstract][Full Text] [Related]
20. Association of N-terminal pro-brain natriuretic peptide level with adverse outcomes in patients with acute myocardial infarction: A meta-analysis.
Shen S; Ye J; Wu X; Li X
Heart Lung; 2021; 50(6):863-869. PubMed ID: 34340134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]